Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.019x

Based on the latest financial reports, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥43.77 Million ≈ $6.41 Million USD) by net assets (CN¥2.26 Billion ≈ $330.53 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Shanghai Fudan-Zhangjiang Bio-Pharmaceut total liabilities for a breakdown of total debt and financial obligations.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Zhongyeda Electric Co Ltd
SHE:002441
-0.038x
Yan Tai Shuang Ta Food Co Ltd
SHE:002481
0.126x
Heritage Insurance Hldgs Inc
NYSE:HRTG
0.284x
MCEWEN MINING INC.
F:US8
N/A
Yieh Phui Enterprise Co Ltd
TW:2023
0.038x
Porch Group Inc
NASDAQ:PRCH
0.054x
Guangdong Greenway Technology Co Ltd
SHG:688345
0.199x
Nuh Cimento Sanayi AS
IS:NUHCM
0.012x

Annual Cash Flow Conversion Efficiency for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (2006–2024)

The table below shows the annual cash flow conversion efficiency of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see Shanghai Fudan-Zhangjiang Bio-Pharmaceut (688505) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥2.31 Billion
≈ $337.33 Million
CN¥-14.77 Million
≈ $-2.16 Million
-0.006x -121.28%
2023-12-31 CN¥2.36 Billion
≈ $345.13 Million
CN¥71.02 Million
≈ $10.39 Million
0.030x -58.95%
2022-12-31 CN¥2.25 Billion
≈ $329.69 Million
CN¥165.27 Million
≈ $24.18 Million
0.073x -40.27%
2021-12-31 CN¥2.19 Billion
≈ $320.41 Million
CN¥268.90 Million
≈ $39.35 Million
0.123x +118.28%
2020-12-31 CN¥2.01 Billion
≈ $293.91 Million
CN¥113.00 Million
≈ $16.54 Million
0.056x -80.50%
2019-12-31 CN¥933.15 Million
≈ $136.55 Million
CN¥269.23 Million
≈ $39.40 Million
0.289x +64.76%
2018-12-31 CN¥993.28 Million
≈ $145.35 Million
CN¥173.94 Million
≈ $25.45 Million
0.175x +265.92%
2017-12-31 CN¥892.48 Million
≈ $130.60 Million
CN¥42.71 Million
≈ $6.25 Million
0.048x -70.28%
2016-12-31 CN¥873.05 Million
≈ $127.76 Million
CN¥140.57 Million
≈ $20.57 Million
0.161x +28.05%
2015-12-31 CN¥765.84 Million
≈ $112.07 Million
CN¥96.30 Million
≈ $14.09 Million
0.126x -3.74%
2014-12-31 CN¥676.42 Million
≈ $98.98 Million
CN¥88.36 Million
≈ $12.93 Million
0.131x -17.35%
2013-12-31 CN¥565.92 Million
≈ $82.81 Million
CN¥89.44 Million
≈ $13.09 Million
0.158x -62.69%
2012-12-31 CN¥260.11 Million
≈ $38.06 Million
CN¥110.19 Million
≈ $16.12 Million
0.424x +71.76%
2011-12-31 CN¥201.07 Million
≈ $29.42 Million
CN¥49.59 Million
≈ $7.26 Million
0.247x +685.36%
2010-12-31 CN¥168.71 Million
≈ $24.69 Million
CN¥-7.11 Million
≈ $-1.04 Million
-0.042x -191.84%
2009-12-31 CN¥168.37 Million
≈ $24.64 Million
CN¥7.72 Million
≈ $1.13 Million
0.046x +121.91%
2008-12-31 CN¥75.88 Million
≈ $11.10 Million
CN¥-15.89 Million
≈ $-2.33 Million
-0.209x +13.44%
2007-12-31 CN¥71.04 Million
≈ $10.40 Million
CN¥-17.18 Million
≈ $-2.51 Million
-0.242x -14.96%
2006-12-31 CN¥101.70 Million
≈ $14.88 Million
CN¥-21.40 Million
≈ $-3.13 Million
-0.210x --

About Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd

SHG:688505 China Drug Manufacturers - Specialty & Generic
Market Cap
$824.00 Million
CN¥5.63 Billion CNY
Market Cap Rank
#10069 Global
#2875 in China
Share Price
CN¥8.01
Change (1 day)
-0.50%
52-Week Range
CN¥7.33 - CN¥11.12
All Time High
CN¥39.80
About

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd., engages in the research, development, manufacture, and sale of bio-pharmaceutical products in the People's Republic of China. It offers genetic engineering platform drugs, including Trop2-SN38 ADC that is in Phase III clinical trials for Triple-negative breast cancer; CD30-DM1 antibody-drug conjugate (ADC), which have complected Phase I clini… Read more